Drug Discovery Informatics Market Size, Share, Growth, Trends and Industry Analysis 2022-2027

According to IMARC Group's latest report, titled "Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global drug discovery informatics market size reached US$ 2.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 11.62% during 2022-2027.

COVID-19 Impact Analysis:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download Free Report Sample Brochure: https://www.imarcgroup.com/drug-discovery-informatics-market/requestsample

Industry Overview and Application:

Drug discovery informatics (DDI) is a technical solution utilized for discovering new treatments and developing effective medications through comprehensive research and screenings. It uses sophisticated bioinformatics algorithms to process biomechanical data related to drugs, proteins, diseases, pathways, gene expression, and sequence data. It also encompasses various hardware and software-based solutions for protecting databases and researching, docking, interpreting, visualizing, and preparing drug formulations cost-effectively. Besides this, DDI analyses new drug entities, handles biological information from multiple sources, and performs several pharmacovigilance tasks and clinical decisions post trials.

Market Trends and Drivers:

The increasing prevalence of various chronic disorders, especially amongst the geriatric population, and the growing need for effective medicines at affordable prices are driving the drug discovery informatics market growth. Additionally, the outbreak of the coronavirus disease (COVID-19) pandemic has prompted governments to invest in the pharmaceutical industry to formulate vaccines, which, in turn, is augmenting the product demand. Apart from this, substantial improvements in the healthcare infrastructure, the advent of in-silico tools and physiologically based pharmacokinetic (PBK) simulator to select pediatric doses, and ongoing research and development (R&D) activities to enhance the drug discovery informatics efficacy are supporting the market growth.

Drug Discovery Informatics Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the drug discovery informatics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Certara
• Charles River Laboratories Inc.
• Collaborative Drug Discovery Inc.
• Eurofins DiscoverX Products
• Infosys Ltd.
• International Business Machines Corporation
• Jubilant Biosys Limited
• Oracle Corporation
• PerkinElmer Inc.
• Selvita
• Thermo Fisher Scientific Inc.

Key Market Segmentation:

The report has segmented the global drug discovery informatics market on the basis of workflow, function, mode, end user and region.

Breakup by Workflow:

• Drug Discovery
• Drug Development

Breakup by Function:

• Sequence Analysis Platforms
• Molecular Modeling
• Molecular Docking
• Clinical Trial Data Management
• Others

Breakup by Mode:

• Outsourced
• In-house

Breakup by End User:

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organization (CROs)
• Others

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3515&flag=C

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.